| Cash Flow | 2025-09-27 |
|---|---|
| Net loss | -20,600 |
| Share-based compensation costs | 36,700 |
| Depreciation | 7,500 |
| Acquired intangible assets amortization | 35,200 |
| Deferred taxes | 4,200 |
| Other | -2,400 |
| Accounts receivable, net | -10,800 |
| Inventories, net | 2,900 |
| Prepaid expenses and other current and non-current assets | -3,900 |
| Accounts payable | -7,000 |
| Accrued liabilities | -31,600 |
| Net cash provided by (used in) operating activities | 30,200 |
| Proceeds from maturity of investments | 61,000 |
| Purchases of property and equipment | 12,200 |
| Net cash provided by (used in) investing activities | 48,800 |
| Repurchases of common stock, excluding excise taxes | 7,200 |
| Proceeds from issuance of shares | 7,400 |
| Payroll taxes related to net share settlement of share-based awards | 10,600 |
| Repayment of debt | 0 |
| Other | 0 |
| Net cash used in financing activities | -10,400 |
| Effect of exchange rate changes on cash and cash equivalents | -200 |
| Net increase (decrease) in cash and cash equivalents | 68,400 |
| Cash and cash equivalents at beginning of period | 391,500 |
| Cash and cash equivalents at end of period | 459,900 |
SYNAPTICS Inc (SYNA)
SYNAPTICS Inc (SYNA)